First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

Published:2012-08 Issue:8 Volume:18 Page:1150-1163
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Martin Paul J.,Rizzo J. Douglas,Wingard John R.,Ballen Karen,Curtin Peter T.,Cutler Corey,Litzow Mark R.,Nieto Yago,Savani Bipin N.,Schriber Jeffrey R.,Shaughnessy Paul J.,Wall Donna A.,Carpenter Paul A.

Funder

Department of Health and Human Services

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference51 articles.

1. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria;Flowers;Blood,2011

2. 1994 Consensus conference on acute GVHD grading;Przepiorka;Bone Marrow Transplant,1995

3. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade;Rowlings;Br J Haematol,1997

4. Treatment of chronic graft-versus-host disease: past, present and future;Martin;Korean J Hematol,2011

5. Secondary treatment of acute graft-versus-host disease: a critical review;Martin;Biol Blood Marrow Transplant,2012

Cited by 502 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program Registry;Transplantation and Cellular Therapy;2024-09

2. Ruxolitinib Plus Basiliximab Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease in Unrelated Cord Blood Transplantation: A Large-Scale Study;Transplantation and Cellular Therapy;2024-09

3. Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease;Best Practice & Research Clinical Haematology;2024-09

4. Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy;Frontiers in Immunology;2024-08-30

5. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD;Blood;2024-08-29